T-0162, a novel free radical scavenger, reduces myocardial infarct size inrabbits

Citation
K. Yamashita et al., T-0162, a novel free radical scavenger, reduces myocardial infarct size inrabbits, CLIN EXP PH, 27(3), 2000, pp. 172-178
Citations number
41
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
ISSN journal
03051870 → ACNP
Volume
27
Issue
3
Year of publication
2000
Pages
172 - 178
Database
ISI
SICI code
0305-1870(200003)27:3<172:TANFRS>2.0.ZU;2-G
Abstract
1. We investigated the effects of 1-(3-tert-butyl-2-hydroxy-5-methoxyphenyl )-3-(3-pyridylmethyl)urea hydrochloride (T-0162), a novel low-molecular wei ght free radical scavenger, on the generation of superoxide anions and hydr oxyl radicals in vitro and in vivo and on myocardial infarct (MI) size in a n in vivo model of MI in rabbits. 2. It was found that T-0162 scavenged both superoxide anions and hydroxyl r adicals in a concentration-dependent manner in vitro. 3. In an in vivo rabbit model with 30 min coronary occlusion and 30 min rep erfusion, T-0162 scavenged hydroxyl radicals generated in the myocardium du ring reperfusion. 4. Anaesthetized open-chest Japanese white male rabbits were subjected to 3 0 min coronary occlusion and 48 h reperfusion. The control group (n = 10) w as infused with 10% lecithin solution for 220 min from 10 min before occlus ion to 180 min after reperfusion. The pretreatment group (n = 10) was infus ed with T-0162 dissolved in 10% lecithin solution for 220 min from 10 min b efore occlusion to 180 min after reperfusion at a rate of 400 mu g/kg per m in. The post-treatment group (n = 10) was injected with an i.v. bolus of 10 mg/kg T-0162 and was then infused with 400 mu g/kg per min T-0162 for 190 min from 10 min before reperfusion to 180 min after reperfusion. After 48 h reperfusion, infarct size was measured histologically and expressed as a p ercentage of area at risk (AAR). 5. There was no significant difference in haemodynamic parameters among the three groups throughout the experimental period. The per cent infarct size of the AAR in the T-0162 groups (24.8 +/- 4.3 and 30.5 +/- 3.9% for pre- a nd posttreatment groups, respectively) was significantly reduced compared w ith control (44.7 +/- 4.1%: P < 0.05). There was no significant difference in the AAR among the three groups. 6. In conclusion, T-0162 reduces MI size through the inhibition of reperfus ion injury.